Literature DB >> 11547902

MUC1, the renaissance molecule.

S J Gendler1.   

Abstract

MUC1 is a large, heavily glycosylated mucin expressed on the apical surfaces of most simple, secretory epithelia including the mammary gland, gastrointestinal, respiratory, urinary and reproductive tracts. Although MUC1 was thought to be an epithelial-specific protein, it is now known to be expressed on a variety of hematopoietic cells as well. Mucins function in protection and lubrication of epithelial surfaces. Transmembrane mucins, which contain cytoplasmic tail domains, appear to have additional functions through their abilities to interact with many proteins involved in signal transduction and cell adhesion. The goal of this review is to highlight recent discoveries that suggest that MUC1 may be a multifunctional protein, located on the surfaces of cells as a sensor of the environment, poised to signal to the interior when things go awry.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11547902     DOI: 10.1023/a:1011379725811

Source DB:  PubMed          Journal:  J Mammary Gland Biol Neoplasia        ISSN: 1083-3021            Impact factor:   2.698


  150 in total

1.  Definition of MHC-restricted CTL epitopes from non-variable number of tandem repeat sequence of MUC1.

Authors:  G A Pietersz; W Li; C Osinski; V Apostolopoulos; I F McKenzie
Journal:  Vaccine       Date:  2000-04-03       Impact factor: 3.641

2.  Structure and expression of the human polymorphic epithelial mucin gene: an expressed VNTR unit.

Authors:  C A Lancaster; N Peat; T Duhig; D Wilson; J Taylor-Papadimitriou; S J Gendler
Journal:  Biochem Biophys Res Commun       Date:  1990-12-31       Impact factor: 3.575

3.  Analysis of mammalian MUC1 genes reveals potential functionally important domains.

Authors:  A P Spicer; T Duhig; B S Chilton; S J Gendler
Journal:  Mamm Genome       Date:  1995-12       Impact factor: 2.957

4.  MUC1 isoform specific monoclonal antibody 6E6/2 detects preferential expression of the novel MUC1/Y protein in breast and ovarian cancer.

Authors:  M Hartman; A Baruch; I Ron; Y Aderet; M Yoeli; O Sagi-Assif; S Greenstein; Y Stadler; M Weiss; E Harness; M Yaakubovits; I Keydar; N I Smorodinsky; D H Wreschner
Journal:  Int J Cancer       Date:  1999-07-19       Impact factor: 7.396

5.  Reactivity of natural and induced human antibodies to MUC1 mucin with MUC1 peptides and n-acetylgalactosamine (GalNAc) peptides.

Authors:  S von Mensdorff-Pouilly; E Petrakou; P Kenemans; K van Uffelen; A A Verstraeten; F G Snijdewint; G J van Kamp; D J Schol; C A Reis; M R Price; P O Livingston; J Hilgers
Journal:  Int J Cancer       Date:  2000-06-01       Impact factor: 7.396

6.  A stat-responsive element in the promoter of the episialin/MUC1 gene is involved in its overexpression in carcinoma cells.

Authors:  I C Gaemers; H L Vos; H H Volders; S W van der Valk; J Hilkens
Journal:  J Biol Chem       Date:  2000-11-17       Impact factor: 5.157

7.  Biophysical characterization of one-, two-, and three-tandem repeats of human mucin (muc-1) protein core.

Authors:  J D Fontenot; N Tjandra; D Bu; C Ho; R C Montelaro; O J Finn
Journal:  Cancer Res       Date:  1993-11-15       Impact factor: 12.701

8.  Tyrosine phosphorylation of the MUC1 breast cancer membrane proteins. Cytokine receptor-like molecules.

Authors:  S Zrihan-Licht; A Baruch; O Elroy-Stein; I Keydar; D H Wreschner
Journal:  FEBS Lett       Date:  1994-12-12       Impact factor: 4.124

9.  Cystic fibrosis mice lacking Muc1 have reduced amounts of intestinal mucus.

Authors:  R R Parmley; S J Gendler
Journal:  J Clin Invest       Date:  1998-11-15       Impact factor: 14.808

10.  MUC1 mucin expression as a marker of progression and metastasis of human colorectal carcinoma.

Authors:  S Nakamori; D M Ota; K R Cleary; K Shirotani; T Irimura
Journal:  Gastroenterology       Date:  1994-02       Impact factor: 22.682

View more
  179 in total

1.  MUC1 gene polymorphism in three Nelore lines selected for growth and its association with growth and carcass traits.

Authors:  Fabio Ricardo Pablos de Souza; Sandra Maione; Stefano Sartore; Dominga Soglia; Veronica Spalenza; Elsa Cauvin; Lucia Regina Martelli; Maria Eugênia Zerlotti Mercadante; Paola Sacchi; Lucia Galvão de Albuquerque; Roberto Rasero
Journal:  Mol Biol Rep       Date:  2011-06-03       Impact factor: 2.316

2.  Tumor cell MUC1 and CD43 are glycosylated differently with sialyl-Lewis a and x epitopes and show variable interactions with E-selectin under physiological flow conditions.

Authors:  J Fernandez-Rodriguez; O Dwir; R Alon; G C Hansson
Journal:  Glycoconj J       Date:  2001 Nov-Dec       Impact factor: 2.916

Review 3.  Membrane-bound mucins: the mechanistic basis for alterations in the growth and survival of cancer cells.

Authors:  S Bafna; S Kaur; S K Batra
Journal:  Oncogene       Date:  2010-03-29       Impact factor: 9.867

Review 4.  Cell-specific aptamer-mediated targeted drug delivery.

Authors:  Jiehua Zhou; John J Rossi
Journal:  Oligonucleotides       Date:  2010-12-23

Review 5.  Nucleic acid aptamers: clinical applications and promising new horizons.

Authors:  X Ni; M Castanares; A Mukherjee; S E Lupold
Journal:  Curr Med Chem       Date:  2011       Impact factor: 4.530

6.  Prevention of lung injury by Muc1 mucin in a mouse model of repetitive Pseudomonas aeruginosa infection.

Authors:  Tsuyoshi Umehara; Kosuke Kato; Yong Sung Park; Erik P Lillehoj; Hideyuki Kawauchi; Kwang Chul Kim
Journal:  Inflamm Res       Date:  2012-05-29       Impact factor: 4.575

Review 7.  Chimeric antigen receptor T cell therapy in pancreatic cancer: from research to practice.

Authors:  Vishal Jindal; Ena Arora; Muhammad Masab; Sorab Gupta
Journal:  Med Oncol       Date:  2018-05-04       Impact factor: 3.064

8.  Binding of the sialic acid-binding lectin, Siglec-9, to the membrane mucin, MUC1, induces recruitment of β-catenin and subsequent cell growth.

Authors:  Shuhei Tanida; Kaoru Akita; Akiko Ishida; Yugo Mori; Munetoyo Toda; Mizue Inoue; Mariko Ohta; Masakazu Yashiro; Tetsuji Sawada; Kosei Hirakawa; Hiroshi Nakada
Journal:  J Biol Chem       Date:  2013-09-17       Impact factor: 5.157

9.  Regulators of gene expression as biomarkers for prostate cancer.

Authors:  Stacey S Willard; Shahriar Koochekpour
Journal:  Am J Cancer Res       Date:  2012-11-20       Impact factor: 6.166

Review 10.  Current status of mucins in the diagnosis and therapy of cancer.

Authors:  Satyanarayana Rachagani; Maria P Torres; Nicolas Moniaux; Surinder K Batra
Journal:  Biofactors       Date:  2009 Nov-Dec       Impact factor: 6.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.